TATFAR was created in 2009 to address the urgent threat of antibiotic resistance. TATFAR’s technical experts from Canada, the European Union (EU), Norway, and the United States collaborate and share best practices to strengthen domestic and global efforts.
The Centers for Disease Control and Prevention (CDC) currently serves as the secretariat for TATFAR, providing administrative support and maintaining the website for the taskforce.
U.S. representatives to TATFAR include the U.S. Department of Health and Human Services (co-chair), NIH (NIAID), CDC, the Food and Drug Administration and the Biomedical Advanced Research and Development Authority.
Main Areas of Focus
TATFAR’s goal is to improve cooperation between the United States and EU in three key areas:
- Appropriate therapeutic use of antimicrobial drugs in medical and veterinary communities
- Prevention of healthcare- and community-associated drug-resistant infections
- Strategies for improving the pipeline of new antimicrobial drugs
Read more about this network: TATFAR